• Amanda M, Ole K, Simonn EB et al. (1999) Anaemia is an independent predictive marker for clinical prognosis in HIV infected patients from across Europe. AIDS 13, 943950.
  • Claster S (2002) Biology of anaemia, differential diagnosis and treatment options in human immunodeficiency virus infection. Journal of Infectious Diseases 15, 105109.
  • Cleveland RP & Liu YC (1996) CD4 expression by erythroid precursor cells in human bone marrow. Blood 87, 2275.
  • Diallo DA, Baby M, Dembele M et al. (2003) Frequency, risk factors and prognostic value of anaemia associated with HIV/AIDS in adults In Mali. Bulletin de la Societe de Pathologie Exotique 96, 123127.
  • Horsburg CR (1991) Mycobacterium avium complex infection in the acquired immuno deficiency syndrome. New England Journal of Medicine 324, 1332.
  • Levine AM, Berhane K, Masri LL et al. (2001) Prevalence and correlates of anaemia in a large cohort of HIV infected women: women’s interagency HIV study. Journal of Acquired Immune Deficiency Syndrome 26, 2835.
  • Moore RD, Keruly J, Richman DD et al. (1992) Natural history of advanced HIV disease in patients treated with zidovudine. AIDS 6, 671677.
  • Morgan D, Malamba S, Gillian HM et al. (1997) An HIV-1 natural history cohort and survival times in rural Uganda. AIDS 11, 633640.
  • Phillips KD & Groer M (2002) Differentiation and treatment of anaemia in HIV disease. Journal of the Association of Nurses in AIDS Care 13, 4768.
  • Semba RD, Shah N, Klein RS et al. (2002) Prevalence and cumulative incidence of and risk factors for anaemia in a multi-center cohort study of human immunodeficiency virus infected and uninfected women. Clinical Infectious Diseases 34, 260266.
  • Spivak JL, Barnes DC, Fuchs E et al. (1998) Serum immunoreactive erythropoietin in HIV infected patients. Journal of the American Medical Association 261, 3104.
  • Ssali F, Stohr W, Munderi P et al. (2006) Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial. Antiviral Therapy 11, 741749.
  • Sullivan PS, Hanson DL, Chu SY et al. (1998) Epidemiology of anaemia in human immunodeficiency virus (HIV) – infected persons: results from the multi site adult and adolescent spectrum of HIV disease surveillance project. Blood 91, 301308.
  • Volberding P (2002) The impact of anaemia on quality of life in Human immunodeficiency virus- infected Patients. Journal of Infectious Diseases 185, 110114.
  • Warrell DA, Cox TM, Firth JD & Benz EJ (2003) The complex and multiple aetiology of anemia in the third world. In: Oxford Text Book of Medicine, 4th edn, Vol, 3 (ed. AnnaCampbell) Oxford University Press, Inc., New York, Ch. 22, p. 645 ff.
  • World Health Organization (1990) Acquired immune deficiency syndrome (AIDS): interim proposal for WHO staging for HIV-1 infection and disease. Weekly Epidemiological Record 65, 221228.
  • World Health Organization (2006) Revised WHO Clinical Staging and Immunological Classification of HIV and Case Definition of HIV for Surveillance. WHO, Geneva.
  • Zauli G, Re MC, Visani G F et al. (1992) Evidence for a human immunodeficiency virus type-1 mediated suppression of uninfected haematopoietic (CD4 + ) cells in AIDS patients. Journal of Infectious Diseases 166, 710.
  • Zon LI, Arkin C & Groopman JE (1987) Haematologic manifestations of human immune deficiency virus (HIV). British Journal of Hematology 66, 251.